Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Venture capital in crisis?

Mason, Colin (2009) Venture capital in crisis? Venture Capital, 11 (4). pp. 279-285. ISSN 1369-1066

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

The venture capital industry is widely thought to be in crisis. The huge amount of money that flowed into the industry in recent years has driven down returns. This has had knock-on effects on fund-raising and investment activity. Many commentators believe that the industry needs to downsize. There are signs that this is already occurring. New investment models are emerging, notably boutique funds, often angel-backed, based on making small investments in early stage businesses and seeking an early exit through a trade sale. Research needs to engage with the venture capital industry's new dynamic. A number of lines of enquiry are proposed.